Clinical Trial: Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07143149) titled 'Effect of the Intelligent Lipid Management Decision-support System on 1-year LDL-C Target Achievement in Ischemic Stroke or TIA Patients Under Evolocumab Treatment in China' on Aug. 04.

Brief Summary: This study will conduct a cluster randomized controlled trial to Evaluate whether the Intelligent Lipid Management Decision-support System can increase the proportion of patients 1-year target achievement (<1.8 mmol/L) in acute ischemic stroke or TIA patients under Evolocumab treatment within 12 months post-intervention.

Study Start Date: Aug. 29

Study Type: INTERVENTIONAL

Condition: Ischemic Stroke Transient Ischemic Attack (TIA)...